Telesta Therapeutics Provides Corporate Update

Type A Meeting request submitted to US FDA
Expenditure reductions implemented and ongoing
Strategic review process initiated

MONTREAL, March 9, 2016 /CNW Telbec/ – Telesta Therapeutics Inc. (TSX:TST)(PNK:BNHLF) today announced that it has submitted a request to meet with the…